We’re twice as fast as our own targets for the time to get studies up and running, latest figures show.

In the three months from July to September 2023, we’re recruiting our first patients into trials within 34 days of opening, on average. That’s over twice as fast as our target of 70 days, and every single study met the target.

The time to open new studies is also significantly shorter than the target of 30 days, with 23 days on average over the same three months.

Director Professor Stephen Ryder said: “This is great news – we know that our partners really value being able to get their studies up and running efficiently. It shows Nottingham Clinical Research Facility offers them a top quality service.”